Sartorius Stedim reported soft Q2 22 numbers with revenue of €861.8m, up 17% on a cc basis, leveraging broad-based growth. EBITDA, at €303.2m, resulted in a margin of 35.2%, down 150bp due to planned increases in opex.
The firm re-iterated FY22 guidance of 15-19% with an EBITDA margin >35%, effectively upgrading its core business guidance as COVID-19-related vaccine normalisation was steeper than expected. We will raise our estimates.
26 Jul 2022
Q2 21: strong underlying business shines through the order book decline
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q2 21: strong underlying business shines through the order book decline
- Published:
26 Jul 2022 -
Author:
Virendra Chauhan -
Pages:
3
Sartorius Stedim reported soft Q2 22 numbers with revenue of €861.8m, up 17% on a cc basis, leveraging broad-based growth. EBITDA, at €303.2m, resulted in a margin of 35.2%, down 150bp due to planned increases in opex.
The firm re-iterated FY22 guidance of 15-19% with an EBITDA margin >35%, effectively upgrading its core business guidance as COVID-19-related vaccine normalisation was steeper than expected. We will raise our estimates.